Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 21, Number 11—November 2015

Letter

Divergent Gemycircularvirus in HIV-Positive Blood, France

On This Page

Tables

Altmetric

Metric Details
13
citations of this article
EID Journal Metrics on Scopus

Cite This Article

Close

Highlight and copy the desired format.

EID Uch R, Fournier P, Robert C, Blanc-Tailleur C, Galicher V, Barre R, et al. Divergent Gemycircularvirus in HIV-Positive Blood, France. Emerg Infect Dis. 2015;21(11):2096-2098. https://dx.doi.org/10.3201/eid2111.150486
AMA Uch R, Fournier P, Robert C, et al. Divergent Gemycircularvirus in HIV-Positive Blood, France. Emerging Infectious Diseases. 2015;21(11):2096-2098. doi:10.3201/eid2111.150486.
APA Uch, R., Fournier, P., Robert, C., Blanc-Tailleur, C., Galicher, V., Barre, R....Biagini, P. (2015). Divergent Gemycircularvirus in HIV-Positive Blood, France. Emerging Infectious Diseases, 21(11), 2096-2098. https://dx.doi.org/10.3201/eid2111.150486.

 To the Editor: Gemycircularviruses are a group of recently discovered single-stranded DNA viruses, found initially in fungi in 2010 (1). These “myco-like” viruses have a genome ranging from 2.1 to 2.3 kb, containing 2 opposite open reading frames that probably code for a capsid protein (CP) and a spliced replication-associated protein (Rep). Related viruses have been subsequently identified in animal blood and fecal matter, raw and treated sewage, and insects and plant material, suggesting that gemycircularviruses may represent a large group of viruses exhibiting considerable genetic diversity (28). The presence of these viruses was recently extended to humans after gemycircularvirus sequences were identified in human blood and brain tissue (multiple sclerosis patient), cerebrospinal fluid, and fecal matter (8,9).

While investigating the virome content of an HIV-positive blood donation, we identified several gemycircularvirus-related sequences. The initial metagenomic approach involved an HIV-1–positive plasma sample (B genotype, ≈530 copies/mL) obtained from the French blood agency national plasma bank in Tours, France. A 4-mL aliquot was prepared for metagenomic analysis after filtration, concentration, and nucleases treatment. Next, particle-protected nucleic acids were recovered and used for the preparation of a next-generation sequencing library and its subsequent analysis (Technical Appendix). Gemycircularvirus sequences identified among reads (1,680 vs. 82,560 reads total; ≈2%) were assembled into a resulting full-length sequence (GemyC1c) by using CodonCode Aligner version 5.1 (CodonCode Corporation, Centerville, MA, USA). This sequence was verified by using back-to-back specific primers, and the amplicon was cloned and sequenced according to the Sanger method.

[[AA:F1:PREVIEWHTML]]

The analysis of the GemyC1c sequence (2,109 nt, GenBank accession no. KP987887) revealed a genome divergent from those already available in databases, despite a similar genomic organization (Figure, panel A) and assignment to gemycircularviruses after BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis of putative CP and Rep proteins. This divergence was demonstrated by the phylogenetic analysis of the deduced CP (Figure, panel B), which exhibited ≈72% and ≈44% aa pairwise identity with the 2 closest gemycircularvirus CP sequences available in GenBank (gemycircularvirus c from mongoose feces [Conceicao-Neto N., unpub. data] and HCBI8.215 from cattle blood, respectively). Moreover, GemyC1c CP exhibited ≈30% pairwise identity with viral sequences identified previously in humans (BZ1 from feces, SL1 from cerebrospinal fluid, MSSI2.225 from blood). The deduced spliced Rep (major Rep1 and minor Rep2), seen in such viruses, contained putative rolling circle motifs I (LFTYS), II (HLHAFVD), and III (YATKD) retrieved from gemycircularviruses (4).

We subsequently investigated the presence of GemyC1c DNA in 128 HIV-positive plasma samples (French blood agency national plasma bank) along with 256 HIV-negative plasma samples (healthy blood donors, southeastern France; mean donor age 38 years; 136 men; 1 man:1.13 women). Plasma samples were prepared as described previously (10), and extracted nucleic acids were tested for GemyC1c DNA by using a specific PCR that included negative, positive, and extraction controls (Technical Appendix).

Application of the above GemyC1c DNA detection system did not generate any positive signal in the 384 plasma samples in this study, suggesting that the presence of this virus in the blood of the populations tested was a rare occurrence. However, it is possible that other, divergent, GemyC1c-related sequences could be present in human blood but remain undetectable by the molecular assay used; the development of universal gemycircularvirus PCR systems is now expected.

Gemycircularviruses are potentially very stable in the environment. Because an unknown part of this group is able to infect fungi, possible contamination from the laboratory environment or nucleic acid extraction methods must be considered. The fact that the same genome was never identified in other libraries generated in our laboratory supports the absence of local contamination; of note, we were also able to detect GemyC1c DNA with PCR by using another plasma aliquot extracted by an alternative method (NucliSENS magnetic extraction; bioMérieux, Marcy l’Étoile, France) In addition, the systematic elimination of the first 35 mL of each blood donation, associated with filtration procedures and control of the temperature of stored plasma (−25°C), contributes to the reduction of bacterial/fungal contamination during blood collection. However, it is not possible to state that the GemyC1c sequence would belong to a human-tropic virus because an association of the virus with an unknown fungus is plausible. Thus, the presence of fungi in the gut, with fungi/virions having traversed the gut lining, or circulating in blood should be considered. Such aspects should prompt future investigations of the effective replication of gemycircularviruses in human or other mammalian cells.

Our discovery of the GemyC1c by a sequence-independent molecular approach was informative for several reasons: 1) this viral sequence would have been undetectable by PCR according to the high genetic divergence existing between GemyC1c and other gemycircularviruses identified; 2) this finding adds clues to the identification of potential new co-infections occurring in HIV-infected persons; and 3) this finding underlines the need to investigate the virome content of blood samples in a research context of new microbes as potential threats for transfusion. Further studies aimed at exploring genetic diversity and natural history of gemycircularviruses in human hosts are needed.

Top

Acknowledgment

This work was supported by grant APR 2013.10 from the Établissement Français du Sang (Paris, France) and by the Méditerranée-Infection foundation.

Top

Rathviro Uch, Pierre-Edouard Fournier, Catherine Robert, Caroline Blanc-Tailleur, Vital Galicher, Romain Barre, François Jordier, Philippe de Micco, Didier Raoult, and Philippe BiaginiComments to Author 

Author affiliations: Centre National de la Recherche Scientifique, Marseilles (R. Uch, P.-E. Fournier, C. Robert, C. Blanc-Tailleur, V. Galicher, R. Barre, F. Jordier, P. de Micco, D. Raoult, P. Biagini); Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France (R. Uch, P.-E. Fournier, C. Robert, C. Blanc-Tailleur, R. Barre, F. Jordier, P. de Micco, D. Raoult, P. Biagini); Aix-Marseille Université, Marseille (R. Uch, P.-E. Fournier, C. Robert, C. Blanc-Tailleur, V. Galicher, R. Barre, F. Jordier, P. de Micco, D. Raoult, P. Biagini); Unité Mixte de Recherche 7268 ADES, Marseilles (R. Uch, V. Galicher, R. Barre, F. Jordier, P. de Micco, P. Biagini); Etablissement Français du Sang, Marseilles (R. Uch, V. Galicher, R. Barre, F. Jordier, P. de Micco, P. Biagini); Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Marseilles (P.-E. Fournier, C. Robert, C. Blanc-Tailleur, D. Raoult)

Top

References

  1. Yu  X, Li  B, Fu  Y, Jiang  D, Ghabrial  SA, Li  G, A geminivirus-related DNA mycovirus that confers hypovirulence to a plant pathogenic fungus. Proc Natl Acad Sci U S A. 2010;107:838792 . DOIPubMed
  2. Rosario  K, Dayaram  A, Marinov  M, Ware  J, Kraberger  S, Staiton  D, Diverse circular ssDNA viruses discovered in dragonflies (Odonata: Epiprocta). J Gen Virol. 2012;93:266881 . DOIPubMed
  3. Dayaram  A, Opong  A, Jaschke  A, Hadfield  J, Baschiera  M, Dobson  RC, Molecular characterization of a novel cassava associated circular ssDNA virus. Virus Res. 2012;166:1305 . DOIPubMed
  4. Sikorski  A, Massaro  M, Kraberger  S, Young  LM, Smalley  D, Martin  DP, Novel myco-like DNA viruses discovered in the faecal matter of various animals. Virus Res. 2013;177:20916. DOIPubMed
  5. Ng  TF, Chen  LF, Zhou  Y, Shapiro  B, Stiller  M, Heintzman  PD, Preservation of viral genomes in 700-y-old caribou feces from a subarctic ice patch. Proc Natl Acad Sci U S A. 2014;111:168427. DOIPubMed
  6. Kraberger  S, Argüello-Astorga  GR, Greenfield  LG, Galilee  C, Law  D, Martin  DP, Characterisation of a diverse range of circular replication-associated protein encoding DNA viruses recovered from a sewage treatment oxidation pond. Infect Genet Evol. 2015;31:7386. DOIPubMed
  7. Kraberger  S, Farkas  K, Bernardo  P, Booker  C, Argüello-Astorga  GR, Mesléard  F, Identification of novel Bromus- and Trifolium-associated circular DNA viruses. Arch Virol. 2015;160:130311. DOIPubMed
  8. Lamberto  I, Gunst  K, Müller  H, zur Hauzen  H, de Villiers  EM. Mycovirus-like DNA virus sequences from cattle serum and human brain samples from multiple sclerosis patients. Genome Announc. 2014;2: pii: e00848–14.
  9. Phan  TG, Mori  D, Deng  X, Rajindrajith  S, Ranawaka  U, Fan Ng  TF, Small circular single stranded DNA viral genomes in unexplained cases of human encephalitis, diarrhea, and in untreated sewage. Virology. 2015;482:98104. DOIPubMed
  10. Biagini  P, Touinssi  M, Galicher  V, de Micco  P. KIs virus and blood donors, France. Emerg Infect Dis. 2012;18:13745. DOIPubMed

Top

Table

Top

Cite This Article

DOI: 10.3201/eid2111.150486

Related Links

Top

Table of Contents – Volume 21, Number 11—November 2015

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Philippe Biagini, Equipe “Emergence et co-évolution virale,” UMR 7268 ADES, Aix-Marseille Université, EFS, CNRS, 27 Blvd Jean Moulin, 13005 Marseille, France


character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

TOP